SEARCH Articles Figures Tables Animal studies carcinogenicity Blood products carcinogenicity studies Carcinogenic effects case-control studies Carcinogenic effects population studies Carcinogenicity experimental studies Carcinogenicity studies Sprague-Dawley rats Carcinogenicity studies biopharmaceuticals Carcinogenicity studies carcinogenic potential assessment Carcinogenicity studies chromium toxicity Carcinogenicity studies clinical indications Carcinogenicity studies clinical trials Carcinogenicity studies design Carcinogenicity studies gene therapies Carcinogenicity studies limitations Carcinogenicity studies models Carcinogenicity studies overview Carcinogenicity studies peptides Carcinogenicity studies perinatal Carcinogenicity studies pharmacological activity Carcinogenicity studies rodent bioassay Carcinogenicity studies short-term assay Carcinogenicity studies testing protocols Carcinogenicity studies transgenic mice Carcinogenicity studies tumor promotion Carcinogenicity studies, polycyclic Carcinogenicity studies, rodent Carcinogenicity studies, rodent neoplasms Carcinogenicity study Carcinogens Case-control studies Carcinogens correlation studies involving EXPERIMENTAL ANIMAL STUDIES AND CARCINOGENICITY European Commission carcinogenicity studies Growth factors carcinogenicity studies Interferons carcinogenicity studies Monoclonal antibodies carcinogenicity studies Mouse carcinogenicity studies Structure activity relationships carcinogenicity studies THRESHOLDS FOR GENOTOXIC CARCINOGENS EVIDENCE FROM MECHANISM-BASED CARCINOGENICITY STUDIES Toxicity studies carcinogenicity testing Tumorigenicity carcinogenicity studies United States carcinogenicity studies